Index RUT
P/E 84.92
EPS (ttm) 0.39
Insider Own 1.04%
Shs Outstand 48.82M
Perf Week 1.24%
Market Cap 1.63B
Forward P/E 31.59
EPS next Y 1.06
Insider Trans 346.66%
Shs Float 48.31M
Perf Month -1.10%
Income 19.44M
PEG 2.83
EPS next Q 0.15
Inst Own 113.59%
Short Float / Ratio 12.60% / 7.40
Perf Quarter -25.13%
Sales 310.19M
P/S 5.26
EPS this Y -18.05%
Inst Trans 1.95%
Short Interest 6.09M
Perf Half Y -34.78%
Book/sh 7.76
P/B 4.31
EPS next Y 5.74%
ROA 4.49%
Target Price 46.00
Perf Year -45.38%
Cash/sh 3.85
P/C 8.67
EPS next 5Y 30.00%
ROE 5.57%
52W Range 30.29 - 81.81
Perf YTD -31.19%
Dividend -
P/FCF -
EPS past 5Y -
ROI 4.74%
52W High -59.17%
Beta 0.85
Dividend % -
Quick Ratio 5.57
Sales past 5Y 26.24%
Gross Margin 77.92%
52W Low 10.27%
ATR 1.73
Employees 964
Current Ratio 6.11
Sales Q/Q 5.60%
Oper. Margin 6.01%
RSI (14) 47.35
Volatility 5.08% 4.23%
Optionable Yes
Debt/Eq 0.09
EPS Q/Q -52.87%
Profit Margin 6.27%
Rel Volume 1.23
Prev Close 31.32
Shortable Yes
LT Debt/Eq 0.08
Earnings Nov 01 AMC
Payout 0.00%
Avg Volume 822.96K
Price 33.40
Recom 2.33
SMA20 0.75%
SMA50 -10.11%
SMA200 -34.09%
Volume 1,012,901
Change 6.64%
Date
Action
Analyst
Rating Change
Price Target Change
Dec-05-23 Downgrade
Needham
Buy → Hold
Dec-04-23 Initiated
Morgan Stanley
Equal-Weight
$35
Sep-15-23 Downgrade
The Benchmark Company
Buy → Hold
Aug-03-23 Downgrade
Canaccord Genuity
Buy → Hold
$77 → $48
Jun-07-23 Downgrade
William Blair
Outperform → Mkt Perform
Apr-17-23 Initiated
Piper Sandler
Neutral
$65
Feb-06-23 Downgrade
BTIG Research
Buy → Neutral
Dec-28-22 Reiterated
BTIG Research
Buy
$80 → $67
Dec-08-22 Initiated
Stifel
Hold
$60
Nov-07-22 Upgrade
Sidoti
Neutral → Buy
Oct-14-22 Resumed
Stephens
Overweight
$91
Oct-13-22 Initiated
Mizuho
Buy
$85
Apr-08-22 Initiated
Needham
Buy
$87
Mar-28-22 Upgrade
The Benchmark Company
Hold → Buy
$97
Mar-18-22 Upgrade
BTIG Research
Neutral → Buy
$98
Jul-09-21 Initiated
Oppenheimer
Perform
$150
Jan-19-21 Downgrade
The Benchmark Company
Buy → Hold
Oct-26-20 Downgrade
Sidoti
Buy → Neutral
Aug-31-20 Upgrade
Sidoti
Neutral → Buy
$58
Aug-06-20 Reiterated
The Benchmark Company
Buy
$50 → $66
Show Previous Ratings
Dec-05-23 03:16AM
Dec-04-23 04:05PM
Nov-15-23 07:00AM
Nov-02-23 05:50PM
09:23AM
(Thomson Reuters StreetEvents)
06:30PM
Loading…
Nov-01-23 06:30PM
05:56PM
04:17PM
(Associated Press Finance)
04:01PM
Oct-31-23 04:40PM
Oct-18-23 04:05PM
Oct-17-23 07:00AM
Oct-13-23 06:30PM
Oct-10-23 10:51AM
Sep-19-23 11:51AM
09:32AM
Loading…
Sep-15-23 09:32AM
Sep-14-23 12:53PM
07:00AM
Sep-08-23 11:38AM
Sep-07-23 05:00PM
Aug-18-23 10:40AM
Aug-17-23 06:48PM
Aug-09-23 07:00AM
Aug-07-23 07:00AM
05:00AM
Aug-03-23 07:18PM
Aug-02-23 05:25PM
04:21PM
04:01PM
Jul-19-23 07:00AM
08:00PM
Loading…
Jun-21-23 08:00PM
Jun-13-23 08:00AM
May-26-23 06:00AM
May-17-23 10:10AM
May-09-23 01:48PM
May-04-23 07:00AM
May-03-23 05:35PM
04:29PM
04:01PM
Apr-27-23 10:02AM
Apr-26-23 08:00PM
10:02AM
Apr-23-23 08:25AM
Apr-19-23 07:00AM
Apr-07-23 11:44AM
Apr-04-23 06:00PM
Mar-29-23 06:00PM
07:00AM
Mar-23-23 06:00PM
Mar-15-23 05:50PM
Mar-13-23 08:48AM
Mar-09-23 05:25AM
Feb-23-23 05:12AM
Feb-21-23 05:15PM
04:01PM
Feb-13-23 05:50PM
Feb-07-23 07:00AM
Feb-03-23 05:50PM
01:58PM
09:00AM
Jan-31-23 09:25AM
Jan-25-23 06:00PM
Jan-24-23 03:26PM
Jan-17-23 06:00PM
Jan-11-23 07:00AM
Jan-10-23 06:41AM
Jan-09-23 07:00AM
Jan-06-23 09:13PM
01:52PM
Dec-30-22 07:17AM
Dec-20-22 08:56AM
Dec-19-22 08:15AM
Dec-13-22 11:01AM
Nov-28-22 01:18PM
Nov-17-22 07:00AM
Nov-13-22 09:28AM
Nov-11-22 08:38AM
Nov-02-22 05:25PM
04:01PM
Oct-29-22 10:49AM
Oct-24-22 12:45PM
Oct-19-22 07:00AM
Oct-12-22 07:00AM
Oct-07-22 12:45PM
Oct-02-22 10:45AM
Sep-19-22 01:39PM
Sep-17-22 08:48AM
(Investor's Business Daily)
Sep-14-22 07:00AM
Sep-05-22 12:45PM
Sep-02-22 04:50PM
(Investor's Business Daily)
Aug-24-22 08:30AM
Aug-18-22 12:45PM
Aug-17-22 12:00PM
Aug-15-22 10:35AM
Aug-11-22 04:17PM
(Investor's Business Daily) +16.69%
03:59PM
Aug-10-22 05:35PM
04:03PM
04:01PM
Aug-03-22 07:07AM
STAAR Surgical Co. engages in the development, manufacture, production, marketing, and sale of implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. It specializes in refractive and cataract solutions. Its products include intraocular lens and implantable collamer lens. The company was founded in 1982 and is headquartered in Lake Forest, CA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Zhou Lilian Yansheng Director Dec 06 Buy 30.74 850 26,129 2,327 Dec 06 04:11 PM BROADWOOD PARTNERS, L.P. 10% Owner Nov 30 Buy 31.42 177,707 5,583,678 10,537,835 Nov 30 07:08 PM BROADWOOD PARTNERS, L.P. 10% Owner Nov 29 Buy 31.39 160,300 5,031,358 10,360,128 Nov 30 07:08 PM BROADWOOD PARTNERS, L.P. 10% Owner Nov 28 Buy 31.85 96,984 3,088,794 10,199,828 Nov 30 07:08 PM BROADWOOD PARTNERS, L.P. 10% Owner Nov 13 Buy 33.04 507 16,749 10,102,844 Nov 14 07:13 PM BROADWOOD PARTNERS, L.P. 10% Owner Nov 10 Buy 32.73 34,320 1,123,383 10,102,337 Nov 14 07:13 PM BROADWOOD PARTNERS, L.P. 10% Owner Nov 09 Buy 33.09 140,000 4,632,581 10,068,017 Nov 09 07:01 PM BROADWOOD PARTNERS, L.P. 10% Owner Nov 08 Buy 33.71 139,409 4,699,073 9,928,017 Nov 09 07:01 PM BROADWOOD PARTNERS, L.P. 10% Owner Nov 07 Buy 34.03 9,731 331,127 9,788,608 Nov 09 07:01 PM BROADWOOD PARTNERS, L.P. 10% Owner Nov 06 Buy 34.16 164,607 5,623,518 9,778,877 Nov 06 07:01 PM BROADWOOD PARTNERS, L.P. 10% Owner Nov 03 Buy 36.06 520 18,753 9,614,270 Nov 06 07:01 PM BROADWOOD PARTNERS, L.P. 10% Owner Nov 02 Buy 35.79 144,027 5,155,243 9,613,750 Nov 06 07:01 PM BROADWOOD PARTNERS, L.P. 10% Owner Oct 06 Buy 37.62 75,299 2,832,417 9,469,723 Oct 06 07:43 PM BROADWOOD PARTNERS, L.P. 10% Owner Oct 05 Buy 37.92 97,474 3,696,399 9,394,424 Oct 06 07:43 PM BROADWOOD PARTNERS, L.P. 10% Owner Oct 04 Buy 37.93 32,523 1,233,649 9,296,950 Oct 06 07:43 PM BROADWOOD PARTNERS, L.P. 10% Owner Sep 21 Buy 39.62 154,814 6,133,467 9,264,427 Sep 21 08:31 PM Lin Elizabeth Yeu Director Sep 21 Buy 40.00 2,500 100,000 2,855 Sep 22 07:18 PM BROADWOOD PARTNERS, L.P. 10% Owner Sep 20 Buy 40.67 132,079 5,372,274 9,109,613 Sep 21 08:31 PM BROADWOOD PARTNERS, L.P. 10% Owner Sep 19 Buy 40.89 4,490 183,613 8,977,534 Sep 21 08:31 PM BROADWOOD PARTNERS, L.P. 10% Owner Sep 07 Buy 41.26 60,874 2,511,722 8,973,044 Sep 07 07:00 PM BROADWOOD PARTNERS, L.P. 10% Owner Sep 06 Buy 41.43 108,944 4,513,735 8,912,170 Sep 07 07:00 PM BROADWOOD PARTNERS, L.P. 10% Owner Sep 05 Buy 41.87 20,144 843,455 8,803,226 Sep 07 07:00 PM Williams Patrick F. Chief Financial Officer Aug 10 Option Exercise 0.00 5,122 0 45,400 Aug 11 06:01 PM WEISNER AIMEE S Director Aug 07 Buy 48.72 2,000 97,440 5,417 Aug 07 04:16 PM FARRELL STEPHEN C Director Jun 15 Option Exercise 0.00 1,709 0 8,276 Jun 16 08:41 PM Kliman Gilbert H Director Jun 15 Option Exercise 0.00 3,417 0 9,656 Jun 16 08:39 PM WEISNER AIMEE S Director Jun 15 Option Exercise 0.00 3,417 0 3,417 Jun 16 08:37 PM Yu K Peony Director Jun 15 Option Exercise 0.00 1,709 0 2,786 Jun 16 08:35 PM Williams Patrick F. Chief Financial Officer Jun 06 Option Exercise 0.00 5,121 0 47,387 Jun 07 04:53 PM Michna Magda Chief Clinical, Regulatory, May 08 Option Exercise 0.00 14,047 0 14,047 May 09 05:26 PM Foust Warren Chief Operating Officer May 08 Option Exercise 0.00 20,331 0 20,331 May 09 05:24 PM Holliday Keith Chief Technology Officer Mar 17 Sale 61.97 823 51,001 27,633 Mar 17 06:04 PM Barnes Scott D Chief Medical Officer Mar 10 Option Exercise 0.00 10,555 0 40,810 Mar 10 09:39 PM Francese James E Sr. VP, Comm. Ops., NA, APAC Mar 10 Option Exercise 0.00 8,388 0 42,374 Mar 10 09:38 PM Gesten Samuel J Chief Legal Officer Mar 10 Option Exercise 0.00 9,531 0 43,219 Mar 10 09:37 PM Holliday Keith Chief Technology Officer Mar 10 Option Exercise 0.00 10,192 0 28,456 Mar 10 09:36 PM Studholme Robert Senior VP, Operations Mar 10 Option Exercise 0.00 8,859 0 31,980 Mar 10 09:34 PM Williams Patrick F. Chief Financial Officer Mar 10 Option Exercise 0.00 12,184 0 45,676 Mar 10 09:35 PM Williams Patrick F. Chief Financial Officer Mar 07 Option Exercise 58.13 1,711 99,460 35,492 Mar 08 08:18 PM Studholme Robert Senior VP, Operations Mar 07 Option Exercise 58.13 1,709 99,344 23,121 Mar 08 08:18 PM Barnes Scott D Chief Medical Officer Mar 07 Option Exercise 58.13 1,603 93,182 32,143 Mar 08 08:14 PM Holliday Keith Chief Technology Officer Mar 07 Option Exercise 58.13 1,431 83,184 19,979 Mar 08 08:17 PM Gesten Samuel J Chief Legal Officer Mar 07 Option Exercise 58.13 1,338 77,778 35,306 Mar 08 08:16 PM Francese James E Sr. VP, Comm. Ops., NA, APAC Mar 07 Option Exercise 58.13 1,083 62,955 35,319 Mar 08 08:15 PM FRINZI THOMAS G President & CEO Jan 03 Option Exercise 0.00 87,805 0 92,534 Jan 04 04:06 PM BROADWOOD PARTNERS, L.P. 10% Owner Dec 29 Buy 47.93 39,090 1,873,431 8,783,082 Dec 29 06:26 PM BROADWOOD PARTNERS, L.P. 10% Owner Dec 28 Buy 46.98 100,000 4,697,610 8,743,992 Dec 29 06:26 PM BROADWOOD PARTNERS, L.P. 10% Owner Dec 27 Buy 47.91 51,985 2,490,534 8,643,992 Dec 29 06:26 PM
Index RUT
P/E -
EPS (ttm) -0.55
Insider Own 28.50%
Shs Outstand 96.12M
Perf Week -3.35%
Market Cap 1.25B
Forward P/E 56.66
EPS next Y 0.19
Insider Trans -2.94%
Shs Float 83.84M
Perf Month -1.75%
Income -64.40M
PEG -
EPS next Q 0.01
Inst Own 74.20%
Short Float / Ratio 9.60% / 6.52
Perf Quarter -12.60%
Sales 654.40M
P/S 1.91
EPS this Y 502.42%
Inst Trans -9.00%
Short Interest 8.05M
Perf Half Y -7.21%
Book/sh 2.60
P/B 4.11
EPS next Y 56.13%
ROA -11.45%
Target Price 15.38
Perf Year -34.03%
Cash/sh 1.84
P/C 5.80
EPS next 5Y -
ROE -21.88%
52W Range 9.50 - 17.88
Perf YTD -20.83%
Dividend -
P/FCF 74.32
EPS past 5Y -
ROI -14.26%
52W High -40.27%
Beta 1.49
Dividend % -
Quick Ratio 1.90
Sales past 5Y 18.08%
Gross Margin 53.43%
52W Low 12.42%
ATR 0.56
Employees 3032
Current Ratio 2.43
Sales Q/Q 14.16%
Oper. Margin -11.02%
RSI (14) 42.27
Volatility 3.55% 4.68%
Optionable Yes
Debt/Eq 0.56
EPS Q/Q 28.66%
Profit Margin -9.84%
Rel Volume 1.69
Prev Close 11.00
Shortable Yes
LT Debt/Eq 0.48
Earnings Nov 08 BMO
Payout -
Avg Volume 1.24M
Price 10.68
Recom 2.12
SMA20 -0.86%
SMA50 -14.33%
SMA200 -11.83%
Volume 2,083,613
Change -2.91%
Date
Action
Analyst
Rating Change
Price Target Change
Oct-12-23 Upgrade
BTIG Research
Neutral → Buy
$17
Oct-03-23 Upgrade
Evercore ISI
In-line → Outperform
$20
Sep-25-23 Initiated
UBS
Neutral
$13
Jun-27-23 Initiated
William Blair
Mkt Perform
May-24-23 Initiated
JMP Securities
Mkt Perform
Mar-01-23 Downgrade
Citigroup
Buy → Neutral
$26 → $13
Feb-07-23 Initiated
BTIG Research
Neutral
Dec-15-22 Initiated
Wolfe Research
Outperform
$20
Jul-22-22 Initiated
Piper Sandler
Overweight
$20
May-18-22 Downgrade
Goldman
Buy → Neutral
$34 → $18
Mar-31-22 Initiated
Stifel
Hold
$36
Oct-26-21 Initiated
Citigroup
Buy
$67
Oct-25-21 Initiated
Telsey Advisory Group
Outperform
$66
Oct-25-21 Initiated
Robert W. Baird
Outperform
$68
Oct-25-21 Initiated
Morgan Stanley
Equal-Weight
$57
Oct-25-21 Initiated
Goldman
Buy
$72
Oct-25-21 Initiated
Evercore ISI
In-line
$54
Oct-25-21 Initiated
Cowen
Outperform
$66
Show Previous Ratings
Today 06:30AM
Dec-04-23 07:00AM
Nov-10-23 04:03PM
Nov-08-23 04:17PM
03:11PM
01:15PM
Loading…
01:15PM
09:30AM
08:03AM
06:45AM
Oct-18-23 04:05PM
Oct-12-23 09:49AM
Oct-03-23 10:27AM
09:54AM
09:45AM
01:18AM
04:05PM
Loading…
Sep-07-23 04:05PM
Aug-27-23 08:00AM
Aug-23-23 09:02PM
Aug-20-23 10:00AM
(The Wall Street Journal)
Aug-12-23 08:05AM
Aug-09-23 03:00PM
10:21AM
10:15AM
09:30AM
08:05AM
06:45AM
Aug-03-23 05:55PM
Jul-23-23 12:11PM
08:09AM
Jul-19-23 08:30AM
04:49PM
Loading…
Jun-29-23 04:49PM
Jun-05-23 08:00AM
May-16-23 09:21AM
May-15-23 07:05AM
May-13-23 12:00AM
(The Wall Street Journal)
May-09-23 01:00PM
06:45AM
May-04-23 12:04PM
May-01-23 07:30AM
Apr-28-23 02:15AM
Apr-18-23 08:30AM
Apr-16-23 02:14PM
Apr-12-23 11:54AM
Apr-07-23 11:02AM
Mar-30-23 02:07PM
Mar-11-23 09:39AM
Mar-09-23 09:17AM
Mar-01-23 12:32AM
(Thomson Reuters StreetEvents) -5.76%
Feb-28-23 11:00AM
10:45AM
07:12AM
06:55AM
Feb-25-23 02:14PM
Feb-17-23 11:00AM
Feb-12-23 09:24AM
Feb-07-23 08:30AM
Jan-30-23 02:24PM
Jan-23-23 10:04AM
Jan-19-23 05:05PM
Jan-11-23 05:57PM
Dec-19-22 01:08PM
Dec-05-22 08:30AM
Nov-17-22 06:18PM
Nov-16-22 05:12AM
(Simply Wall St.) -10.80%
Nov-10-22 02:30PM
08:05AM
08:02AM
07:08AM
06:45AM
Nov-09-22 07:15AM
Nov-08-22 08:25AM
Nov-02-22 03:38PM
Oct-20-22 12:39PM
08:30AM
Oct-12-22 05:25AM
Oct-05-22 12:52PM
Oct-03-22 12:55PM
Oct-02-22 09:02AM
Sep-30-22 09:55AM
Sep-26-22 03:09PM
(American City Business Journals)
Sep-22-22 12:28PM
Sep-19-22 06:30AM
Sep-06-22 04:15PM
Sep-05-22 08:44AM
Aug-29-22 12:15AM
Aug-22-22 08:48AM
Aug-19-22 09:53AM
Aug-16-22 05:47PM
01:51AM
Aug-15-22 08:19AM
Aug-11-22 05:14PM
(The Wall Street Journal) +19.18%
03:19PM
11:30AM
10:52AM
07:54AM
07:06AM
06:49AM
Jul-30-22 07:01AM
Jul-22-22 10:46AM
Jul-21-22 09:56AM
Warby Parker, Inc. operates as an online retailer of eyewear for men and women. It engages in the business of selling eyewear products and providing optical services directly to consumers through its retail stores and e-commerce platform. Its products include eyeglasses, sunglasses and contacts. The company was founded by Neil Blumenthal, Andrew Martin Hunt, Jeffrey J. Raider and David Gilboa on May 7, 2010 and is headquartered in New York, NY.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Miller Steven Clive Chief Financial Officer Sep 08 Option Exercise 0.00 18,482 0 194,859 Sep 12 06:02 PM Briggs Teresa Director Sep 08 Option Exercise 0.00 2,149 0 15,969 Sep 12 06:03 PM Miller Steven Clive Chief Financial Officer Sep 08 Sale 11.92 7,607 90,675 187,252 Sep 12 06:02 PM Blumenthal Neil Harris Co-Chief Executive Officer Sep 08 Sale 11.92 5,016 59,791 106 Sep 12 06:05 PM Gilboa David Abraham Co-Chief Executive Officer Sep 08 Sale 11.92 5,016 59,791 235 Sep 12 06:00 PM Durable Capital Partners LP 10% Owner Aug 21 Sale 12.23 402,535 4,923,003 9,690,563 Aug 23 05:00 PM Briggs Teresa Director Aug 14 Sale 12.94 9,720 125,788 13,820 Aug 16 05:12 PM Durable Capital Partners LP 10% Owner Jun 22 Sale 11.91 24,151 287,638 10,093,098 Jun 26 05:00 PM Durable Capital Partners LP 10% Owner Jun 21 Sale 11.91 218,088 2,597,105 10,117,249 Jun 22 05:00 PM Durable Capital Partners LP 10% Owner Jun 20 Sale 11.90 2,522 30,012 10,335,337 Jun 22 05:00 PM Durable Capital Partners LP 10% Owner Jun 16 Sale 11.96 49,620 593,455 10,337,859 Jun 20 05:00 PM Durable Capital Partners LP 10% Owner Jun 15 Sale 11.91 38,617 459,928 10,387,479 Jun 20 05:00 PM Durable Capital Partners LP 10% Owner Jun 14 Sale 12.04 16,745 201,612 10,426,096 Jun 15 05:00 PM Durable Capital Partners LP 10% Owner Jun 13 Sale 12.03 158,619 1,907,630 10,442,841 Jun 15 05:00 PM Miller Steven Clive Chief Financial Officer Jun 09 Option Exercise 0.00 18,482 0 184,029 Jun 12 05:36 PM Briggs Teresa Director Jun 09 Option Exercise 0.00 2,147 0 23,540 Jun 12 05:36 PM Miller Steven Clive Chief Financial Officer Jun 09 Sale 11.69 7,652 89,452 176,377 Jun 12 05:36 PM Blumenthal Neil Harris Co-Chief Executive Officer Jun 09 Sale 11.69 5,043 58,953 106 Jun 12 05:35 PM Gilboa David Abraham Co-Chief Executive Officer Jun 09 Sale 11.69 5,043 58,953 235 Jun 12 05:35 PM Durable Capital Partners LP 10% Owner Jun 09 Sale 12.00 200 2,400 10,601,460 Jun 12 05:39 PM Durable Capital Partners LP 10% Owner Jun 08 Sale 12.02 56,828 682,859 10,601,660 Jun 12 05:39 PM Durable Capital Partners LP 10% Owner Jun 07 Sale 12.10 306,501 3,710,069 10,658,488 Jun 08 05:36 PM Durable Capital Partners LP 10% Owner Jun 06 Sale 12.16 70,920 862,324 10,964,989 Jun 08 05:36 PM Miller Steven Clive Chief Financial Officer Mar 13 Sale 10.89 8,251 89,818 165,547 Mar 14 04:34 PM Briggs Teresa Director Mar 10 Option Exercise 0.00 2,147 0 21,393 Mar 14 04:35 PM Miller Steven Clive Chief Financial Officer Mar 10 Option Exercise 0.00 14,251 0 179,798 Mar 14 04:34 PM Blumenthal Neil Harris Co-Chief Executive Officer Mar 10 Sale 11.04 6,517 71,948 106 Mar 14 04:33 PM Gilboa David Abraham Co-Chief Executive Officer Mar 10 Sale 11.04 6,517 71,948 235 Mar 14 04:33 PM Miller Steven Clive Chief Financial Officer Mar 10 Sale 11.04 6,000 66,240 173,798 Mar 14 04:34 PM Briggs Teresa Director Mar 07 Sale 12.05 18,900 227,800 19,246 Mar 09 04:30 PM Durable Capital Partners LP 10% Owner Feb 03 Sale 17.01 9,512 161,798 11,035,909 Feb 06 05:18 PM Durable Capital Partners LP 10% Owner Feb 02 Sale 17.27 566,382 9,782,370 11,045,421 Feb 06 05:18 PM Durable Capital Partners LP 10% Owner Jan 27 Sale 17.02 28,300 481,770 11,611,803 Jan 30 09:52 AM Durable Capital Partners LP 10% Owner Jan 26 Sale 17.12 10,009 171,354 11,640,103 Jan 30 09:52 AM Durable Capital Partners LP 10% Owner Jan 24 Sale 17.00 13,968 237,456 11,650,112 Jan 26 09:15 AM Durable Capital Partners LP 10% Owner Jan 18 Sale 17.00 2,686 45,662 11,664,080 Jan 19 09:54 AM Durable Capital Partners LP 10% Owner Jan 17 Sale 16.61 5,540 92,019 11,666,766 Jan 19 09:54 AM Gilboa David Abraham Co-Chief Executive Officer Dec 14 Sale 15.73 10,738 168,863 235 Dec 19 06:37 PM Blumenthal Neil Harris Co-Chief Executive Officer Dec 14 Sale 15.73 10,738 168,863 106 Dec 19 06:33 PM Miller Steven Clive Chief Financial Officer Dec 12 Sale 16.73 7,150 119,587 165,547 Dec 13 08:46 PM
Index RUT
P/E -
EPS (ttm) -1.72
Insider Own 17.35%
Shs Outstand 35.86M
Perf Week 18.70%
Market Cap 1.25B
Forward P/E -
EPS next Y -1.31
Insider Trans -14.80%
Shs Float 29.64M
Perf Month 40.78%
Income -55.04M
PEG -
EPS next Q -0.40
Inst Own 71.14%
Short Float / Ratio 4.41% / 2.56
Perf Quarter 15.95%
Sales 76.59M
P/S 16.37
EPS this Y 35.32%
Inst Trans -1.07%
Short Interest 1.31M
Perf Half Y 34.92%
Book/sh 4.50
P/B 7.76
EPS next Y 16.10%
ROA -32.61%
Target Price 34.00
Perf Year 153.04%
Cash/sh 3.68
P/C 9.51
EPS next 5Y 19.00%
ROE -42.76%
52W Range 10.29 - 34.20
Perf YTD 176.01%
Dividend -
P/FCF -
EPS past 5Y -
ROI -33.80%
52W High 2.25%
Beta 1.07
Dividend % -
Quick Ratio 7.87
Sales past 5Y 241.93%
Gross Margin 56.84%
52W Low 239.84%
ATR 1.31
Employees 292
Current Ratio 8.87
Sales Q/Q 75.97%
Oper. Margin -70.80%
RSI (14) 78.52
Volatility 4.23% 4.86%
Optionable Yes
Debt/Eq 0.02
EPS Q/Q 42.74%
Profit Margin -71.87%
Rel Volume 0.93
Prev Close 34.16
Shortable Yes
LT Debt/Eq 0.01
Earnings Nov 09 AMC
Payout -
Avg Volume 511.30K
Price 34.97
Recom 1.29
SMA20 20.49%
SMA50 32.38%
SMA200 41.85%
Volume 477,628
Change 2.37%
Date
Action
Analyst
Rating Change
Price Target Change
Dec-04-23 Initiated
Morgan Stanley
Overweight
$36
Apr-13-23 Initiated
Oppenheimer
Outperform
$23
Dec-12-22 Downgrade
Wells Fargo
Overweight → Equal Weight
$20 → $14
Apr-08-22 Initiated
Needham
Buy
$18
Nov-15-23 09:30AM
Nov-12-23 10:26AM
Nov-10-23 07:42AM
(Thomson Reuters StreetEvents) +6.22%
Nov-09-23 04:05PM
Nov-02-23 09:00AM
04:05PM
Loading…
Oct-26-23 04:05PM
Sep-07-23 09:35AM
Aug-23-23 04:05PM
Aug-22-23 05:20PM
Aug-18-23 09:23AM
Aug-17-23 08:37AM
Aug-08-23 08:44AM
06:21AM
(Thomson Reuters StreetEvents)
Aug-07-23 06:15PM
04:05PM
04:05PM
Loading…
Jul-25-23 04:05PM
Jun-30-23 08:31AM
Jun-27-23 08:38AM
Jun-18-23 10:53AM
May-10-23 07:52AM
(Thomson Reuters StreetEvents) +9.87%
May-09-23 06:15PM
04:05PM
May-03-23 10:00AM
May-02-23 10:02AM
Apr-26-23 06:33PM
04:05PM
Apr-25-23 04:05PM
Apr-24-23 04:05PM
Apr-18-23 11:26AM
Apr-11-23 12:00PM
04:05PM
Loading…
Apr-05-23 04:05PM
Mar-13-23 09:55AM
Mar-08-23 07:21AM
Mar-07-23 08:23AM
(Thomson Reuters StreetEvents)
05:16AM
Mar-06-23 04:05PM
Feb-28-23 04:05PM
Feb-21-23 04:05PM
Feb-14-23 04:05PM
Feb-08-23 12:45AM
Feb-07-23 04:05PM
Jan-09-23 08:56AM
Jan-08-23 04:00PM
Dec-31-22 06:15AM
Dec-28-22 04:05PM
Dec-22-22 09:40AM
Dec-06-22 09:40AM
Dec-02-22 09:55AM
Nov-16-22 09:55AM
Nov-09-22 06:10AM
Nov-07-22 06:15PM
04:05PM
Nov-03-22 10:00AM
Oct-31-22 10:01AM
Oct-24-22 04:05PM
Oct-12-22 06:56AM
Aug-24-22 04:05PM
Aug-22-22 01:45PM
Aug-08-22 11:30PM
05:35PM
04:10PM
04:05PM
Aug-02-22 06:27AM
Jul-25-22 04:05PM
May-08-22 08:21AM
May-06-22 11:00AM
May-05-22 04:05PM
May-04-22 03:51PM
Apr-22-22 09:00AM
Apr-21-22 04:05PM
Apr-19-22 04:30PM
Mar-28-22 04:05PM
Mar-08-22 09:30PM
04:05PM
Mar-04-22 06:38AM
Mar-01-22 08:00AM
Feb-23-22 04:10PM
Feb-03-22 04:05PM
Jan-09-22 04:00PM
Jan-04-22 04:05PM
Dec-28-21 04:05PM
Nov-18-21 04:05PM
Nov-11-21 11:30AM
Nov-10-21 04:05PM
Nov-02-21 03:41PM
Oct-27-21 04:05PM
Sep-09-21 04:05PM
Sep-01-21 08:00AM
Aug-31-21 08:00AM
Aug-24-21 04:05PM
02:14PM
Aug-17-21 04:05PM
Aug-10-21 08:05PM
Aug-04-21 04:05PM
Jul-29-21 10:17PM
RxSight, Inc. engages in the research, development, manufacture, and sale of light adjustable lenses and related capital equipment. It also commercializes adjustable intraocular lens (IOL) that is customized after cataract surgery. The company was founded on March 5, 1997 and is headquartered in Aliso Viejo, CA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Tammenoms Bakker Juliet Director Nov 29 Sale 29.77 349,245 10,398,665 0 Nov 30 07:32 PM Tammenoms Bakker Juliet Director Nov 28 Sale 29.62 145,068 4,297,030 349,245 Nov 30 07:32 PM Tammenoms Bakker Juliet Director Nov 15 Sale 27.20 400,000 10,878,160 494,313 Nov 16 07:31 PM Tammenoms Bakker Juliet Director Nov 14 Sale 27.13 100,000 2,712,590 894,313 Nov 16 07:31 PM Tammenoms Bakker Juliet Director Sep 11 Sale 30.01 2,950 88,525 20,223 Sep 11 06:15 PM Tammenoms Bakker Juliet Director Sep 08 Sale 30.25 10,033 303,461 23,173 Sep 11 06:15 PM Tammenoms Bakker Juliet Director Sep 07 Sale 30.10 19,967 600,983 33,206 Sep 11 06:15 PM Maniar Shweta Director Aug 29 Sale 28.06 4,292 120,451 24,947 Aug 29 05:10 PM Tammenoms Bakker Juliet Director Aug 25 Sale 29.25 16,208 474,129 53,173 Aug 28 07:44 PM Tammenoms Bakker Juliet Director Aug 18 Sale 29.07 14,651 425,877 68,411 Aug 18 04:08 PM Tammenoms Bakker Juliet Director Aug 17 Sale 30.06 18,484 555,694 83,062 Aug 18 04:08 PM Goldshleger Ilya Chief Operating Officer Jul 26 Option Exercise 3.93 25,475 100,000 26,475 Jul 27 04:44 PM Tammenoms Bakker Juliet Director Feb 10 Buy 12.50 480,000 6,000,000 980,000 Feb 13 06:20 PM
Index RUT
P/E -
EPS (ttm) -0.86
Insider Own 1.81%
Shs Outstand 78.99M
Perf Week -2.19%
Market Cap 1.47B
Forward P/E 34.12
EPS next Y 0.55
Insider Trans 0.00%
Shs Float 76.83M
Perf Month 11.52%
Income -59.17M
PEG -
EPS next Q -0.09
Inst Own 102.82%
Short Float / Ratio 10.60% / 5.57
Perf Quarter 11.32%
Sales 2.09B
P/S 0.70
EPS this Y -13.01%
Inst Trans -1.66%
Short Interest 8.15M
Perf Half Y -27.99%
Book/sh 10.75
P/B 1.75
EPS next Y -2.67%
ROA -2.60%
Target Price 20.90
Perf Year -53.18%
Cash/sh 3.40
P/C 5.53
EPS next 5Y 7.70%
ROE -6.77%
52W Range 13.71 - 43.82
Perf YTD -51.55%
Dividend -
P/FCF 37.81
EPS past 5Y -5.48%
ROI -3.35%
52W High -57.14%
Beta 1.35
Dividend % -
Quick Ratio 1.02
Sales past 5Y 8.23%
Gross Margin 48.54%
52W Low 36.98%
ATR 0.77
Employees 13975
Current Ratio 1.34
Sales Q/Q 6.64%
Oper. Margin 1.57%
RSI (14) 53.03
Volatility 3.52% 4.42%
Optionable Yes
Debt/Eq 1.21
EPS Q/Q -751.17%
Profit Margin -2.83%
Rel Volume 0.41
Prev Close 19.45
Shortable Yes
LT Debt/Eq 1.10
Earnings Nov 09 BMO
Payout 0.00%
Avg Volume 1.46M
Price 18.78
Recom 2.36
SMA20 -1.23%
SMA50 10.57%
SMA200 -8.91%
Volume 597,912
Change -3.44%
Date
Action
Analyst
Rating Change
Price Target Change
Oct-17-23 Downgrade
Goldman
Buy → Neutral
$25 → $16
Jul-27-23 Downgrade
Wells Fargo
Overweight → Equal Weight
$30 → $21
Jul-27-23 Downgrade
Citigroup
Buy → Neutral
$28 → $22
May-02-23 Downgrade
Barclays
Overweight → Equal Weight
Mar-31-23 Upgrade
Loop Capital
Hold → Buy
$23
Jan-17-23 Downgrade
Morgan Stanley
Overweight → Equal-Weight
Nov-07-22 Resumed
Jefferies
Buy
$40 → $45
Jun-27-22 Upgrade
Goldman
Neutral → Buy
$31 → $32
Nov-15-21 Downgrade
Goldman
Buy → Neutral
$59 → $57
Nov-12-21 Downgrade
BofA Securities
Buy → Underperform
$63 → $50
Oct-14-21 Upgrade
Morgan Stanley
Equal-Weight → Overweight
$70
Aug-27-21 Downgrade
Morgan Stanley
Overweight → Equal-Weight
$58 → $57
Jan-11-21 Downgrade
Loop Capital
Buy → Hold
Nov-18-20 Downgrade
Berenberg
Buy → Hold
$42
Feb-04-20 Initiated
BMO Capital Markets
Market Perform
Feb-03-20 Initiated
BMO Capital Markets
Market Perform
Nov-13-19 Initiated
Barclays
Overweight
$34
Oct-01-19 Upgrade
BofA/Merrill
Neutral → Buy
Aug-07-19 Upgrade
Loop Capital
Hold → Buy
$30 → $37
Jul-11-19 Initiated
Goldman
Buy
$33
Show Previous Ratings
Dec-07-23 06:59AM
Nov-10-23 02:10PM
08:08AM
07:34AM
Nov-09-23 07:04AM
06:39AM
Loading…
06:39AM
06:37AM
(Associated Press Finance)
06:28AM
06:00AM
Oct-31-23 08:00AM
Oct-26-23 08:00AM
Oct-19-23 08:30AM
Oct-05-23 04:31PM
Sep-11-23 11:21AM
Sep-05-23 04:05PM
08:48AM
Loading…
Aug-11-23 08:48AM
Aug-10-23 10:47PM
(Thomson Reuters StreetEvents) -5.54%
09:08AM
06:25AM
(Associated Press Finance)
06:00AM
Aug-09-23 08:32AM
Aug-02-23 12:00PM
Jul-26-23 04:05PM
Jul-20-23 09:00AM
Jul-13-23 04:05PM
Jul-06-23 09:00AM
Jul-01-23 10:30AM
Jun-30-23 10:50PM
Jun-21-23 09:42AM
Jun-05-23 10:26AM
08:00AM
Loading…
Jun-01-23 08:00AM
May-19-23 06:01AM
May-12-23 11:48AM
07:51AM
12:19AM
(Thomson Reuters StreetEvents)
May-11-23 06:12AM
06:00AM
May-09-23 02:32AM
May-07-23 09:43AM
May-04-23 06:26AM
May-02-23 08:02AM
May-01-23 09:00AM
Apr-27-23 08:00AM
Apr-17-23 04:17PM
Apr-05-23 12:03PM
Mar-22-23 11:52AM
Mar-08-23 08:00AM
07:04AM
Mar-03-23 08:00AM
Mar-02-23 11:28AM
03:26AM
(Thomson Reuters StreetEvents)
Mar-01-23 02:27PM
02:00PM
06:00AM
Feb-23-23 08:44AM
Feb-15-23 08:00AM
Jan-22-23 08:49AM
Dec-29-22 09:35AM
Dec-27-22 09:00AM
Dec-20-22 10:41AM
Nov-27-22 09:43AM
Nov-15-22 10:00AM
08:00AM
Nov-12-22 07:45AM
Nov-10-22 07:15AM
06:00AM
Nov-09-22 08:32AM
Nov-08-22 10:00AM
07:55AM
Nov-03-22 10:00AM
08:30AM
Nov-01-22 02:06PM
Oct-27-22 11:40AM
08:00AM
Oct-26-22 12:10PM
Oct-13-22 10:44AM
Sep-16-22 09:38AM
Aug-31-22 08:00AM
Aug-15-22 09:17AM
07:11AM
Aug-11-22 05:00PM
07:42AM
07:15AM
06:01AM
06:00AM
Aug-10-22 08:58AM
Aug-09-22 10:00AM
Aug-04-22 10:00AM
Jul-28-22 08:00AM
Jul-21-22 09:02AM
Jul-20-22 09:32AM
09:15AM
Jul-06-22 09:30AM
Jun-28-22 02:25PM
Jun-22-22 10:41AM
Jun-21-22 12:14PM
Jun-20-22 09:56AM
Jun-13-22 07:00PM
Jun-09-22 11:30AM
Jun-03-22 11:54AM
National Vision Holdings, Inc. engages in the retail of optical products. It operates through the following segments: Owned and Host, Legacy, and Corporate/Other. The Owned and Host segment offers America's Best and Eyeglass World brands. The Legacy segment includes inventory and lab processing services. The Corporate/Other segment consists of the results of operations of the other operating segments and corporate overhead support. The company was founded in 1990 and is headquartered in Duluth, GA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Moore Patrick R. Chief Operating Officer Nov 18 Option Exercise 0.00 2,745 0 49,619 Nov 21 04:31 PM Rasmussen Melissa Chief Financial Officer Nov 18 Option Exercise 0.00 2,745 0 15,301 Nov 21 04:33 PM Moore Patrick R. Chief Operating Officer Oct 05 Option Exercise 0.00 2,888 0 47,744 Oct 10 04:16 PM PEELER D RANDOLPH Director May 23 Buy 25.73 17,609 453,080 148,880 May 24 04:42 PM PEELER D RANDOLPH Director May 22 Buy 25.59 22,861 585,013 131,271 May 24 04:42 PM TAYLOR THOMAS V Director May 17 Buy 24.04 2,079 49,979 25,556 May 19 04:30 PM FAHS L READE Chief Executive Officer May 15 Buy 23.81 12,625 300,601 556,550 May 17 12:22 PM VanDette Joseph SVP, Chief Marketing Officer Apr 11 Option Exercise 0.00 2,986 0 2,576 Apr 13 04:21 PM Acharya Ravi SVP, Chief Technology Officer Mar 16 Option Exercise 0.00 897 0 8,129 Mar 20 04:42 PM FAHS L READE Chief Executive Officer Mar 03 Option Exercise 0.00 5,019 0 546,186 Mar 07 04:30 PM Clark Bill SVP, Chief People Officer Mar 03 Option Exercise 0.00 639 0 22,518 Mar 07 04:32 PM Acharya Ravi SVP, Chief Technology Officer Mar 03 Option Exercise 0.00 639 0 7,459 Mar 07 04:45 PM Brandman Jared SVP, GC and Secretary Mar 03 Option Exercise 0.00 639 0 25,635 Mar 07 04:42 PM Rasmussen Melissa Chief Financial Officer Mar 03 Option Exercise 0.00 320 0 12,552 Mar 07 04:39 PM Moore Patrick R. Chief Operating Officer Mar 03 Option Exercise 0.00 1,278 0 45,309 Mar 07 04:41 PM Acharya Ravi SVP, Chief Technology Officer Mar 02 Option Exercise 0.00 7,894 0 8,662 Mar 06 04:55 PM Clark Bill SVP, Chief People Officer Mar 02 Option Exercise 0.00 7,050 0 23,529 Mar 06 04:53 PM Brandman Jared SVP, GC and Secretary Mar 02 Option Exercise 0.00 5,961 0 26,348 Mar 06 04:51 PM Rasmussen Melissa Chief Financial Officer Mar 02 Option Exercise 0.00 4,017 0 13,113 Mar 06 04:50 PM Moore Patrick R. Chief Operating Officer Mar 02 Option Exercise 0.00 18,594 0 48,699 Mar 06 04:48 PM FAHS L READE Chief Executive Officer Mar 02 Option Exercise 0.00 49,164 0 556,929 Mar 06 04:46 PM Clark Bill SVP, Chief People Officer Feb 28 Option Exercise 0.00 766 0 17,377 Mar 02 04:43 PM Brandman Jared SVP, GC and Secretary Feb 28 Option Exercise 0.00 599 0 21,214 Mar 02 04:41 PM Moore Patrick R. Chief Operating Officer Feb 28 Option Exercise 0.00 2,394 0 31,839 Mar 02 04:39 PM Rasmussen Melissa Chief Financial Officer Feb 28 Option Exercise 0.00 383 0 9,759 Mar 02 04:37 PM FAHS L READE Chief Executive Officer Feb 28 Option Exercise 0.00 5,385 0 515,798 Mar 02 04:35 PM Acharya Ravi SVP, Chief Technology Officer Jan 05 Option Exercise 23.25 562 13,066 1,394 Jan 06 04:30 PM Acharya Ravi SVP, Chief Technology Officer Jan 04 Option Exercise 23.25 3,613 84,002 4,445 Jan 06 04:30 PM Acharya Ravi SVP, Chief Technology Officer Jan 04 Sale 40.00 1,394 55,760 832 Jan 06 04:30 PM
Index S&P 500
P/E 56.74
EPS (ttm) 5.90
Insider Own 0.55%
Shs Outstand 49.50M
Perf Week -1.78%
Market Cap 16.59B
Forward P/E 21.42
EPS next Y 15.64
Insider Trans 0.00%
Shs Float 49.25M
Perf Month 0.70%
Income 294.20M
PEG 5.67
EPS next Q 3.15
Inst Own 99.08%
Short Float / Ratio 1.35% / 2.28
Perf Quarter -4.72%
Sales 3.59B
P/S 4.62
EPS this Y 8.56%
Inst Trans -3.99%
Short Interest 0.66M
Perf Half Y -3.22%
Book/sh 152.54
P/B 2.20
EPS next Y 12.45%
ROA 2.54%
Target Price 383.41
Perf Year 6.49%
Cash/sh 2.44
P/C 137.21
EPS next 5Y 10.00%
ROE 4.00%
52W Range 303.74 - 399.62
Perf YTD 1.31%
Dividend 0.04
P/FCF 77.16
EPS past 5Y 15.98%
ROI 2.86%
52W High -16.17%
Beta 0.94
Dividend % 0.01%
Quick Ratio 1.00
Sales past 5Y 7.68%
Gross Margin 60.44%
52W Low 10.29%
ATR 7.69
Employees 15000
Current Ratio 1.76
Sales Q/Q 9.31%
Oper. Margin 14.84%
RSI (14) 50.00
Volatility 2.33% 2.21%
Optionable Yes
Debt/Eq 0.37
EPS Q/Q 28.04%
Profit Margin 8.19%
Rel Volume 1.98
Prev Close 344.95
Shortable Yes
LT Debt/Eq 0.36
Earnings Dec 07 AMC
Payout 0.77%
Avg Volume 291.51K
Price 335.00
Recom 2.17
SMA20 -0.62%
SMA50 2.58%
SMA200 -6.20%
Volume 577,795
Change -2.88%
Date
Action
Analyst
Rating Change
Price Target Change
Oct-30-23 Initiated
BofA Securities
Buy
$380
Oct-05-23 Downgrade
Redburn Atlantic
Overweight → Neutral
$390 → $343
May-30-23 Initiated
Morgan Stanley
Equal-Weight
$410
Dec-22-22 Initiated
Mizuho
Buy
$375
Nov-30-22 Upgrade
Robert W. Baird
Neutral → Outperform
$345 → $375
Oct-12-22 Downgrade
Jefferies
Buy → Hold
$400 → $295
Aug-29-22 Downgrade
KeyBanc Capital Markets
Overweight → Sector Weight
May-17-22 Upgrade
Citigroup
Neutral → Buy
$460 → $405
Apr-08-22 Initiated
Needham
Hold
Jan-03-22 Upgrade
Guggenheim
Neutral → Buy
Sep-03-21 Reiterated
Stifel
Buy
$450 → $475
Sep-03-21 Reiterated
Oppenheimer
Perform
$405 → $475
Sep-03-21 Reiterated
KeyBanc Capital Markets
Overweight
$444 → $476
Sep-03-21 Reiterated
Citigroup
Neutral
$400 → $453
Apr-23-21 Initiated
Redburn
Buy
Jul-06-20 Downgrade
Robert W. Baird
Outperform → Neutral
$291
Mar-05-20 Initiated
Citigroup
Neutral
$360
Feb-01-19 Upgrade
Stephens
Equal-Weight → Overweight
$305
Jan-04-19 Downgrade
Goldman
Neutral → Sell
Jul-30-18 Upgrade
KeyBanc Capital Mkts
Sector Weight → Overweight
Show Previous Ratings
Dec-09-23 01:05AM
Dec-08-23 02:11PM
12:57PM
(Associated Press Finance)
09:17AM
09:14AM
07:15AM
Loading…
07:15AM
(Thomson Reuters StreetEvents)
Dec-07-23 06:00PM
05:10PM
04:58PM
04:36PM
(Associated Press Finance)
04:15PM
Dec-05-23 02:20PM
Dec-04-23 12:44PM
Nov-30-23 04:15PM
10:00AM
09:31AM
Loading…
Nov-28-23 09:31AM
Nov-24-23 01:25AM
Nov-02-23 04:15PM
Nov-01-23 04:15PM
Oct-30-23 09:43AM
Oct-19-23 11:40AM
Oct-13-23 11:33AM
07:36AM
Sep-27-23 12:03PM
Sep-14-23 12:30PM
Sep-12-23 04:15PM
Sep-11-23 04:15PM
Sep-08-23 03:44PM
Sep-05-23 12:03PM
Aug-31-23 12:06PM
11:35AM
Loading…
11:35AM
10:14AM
08:39AM
08:19AM
06:41AM
(Thomson Reuters StreetEvents)
Aug-30-23 06:00PM
06:00PM
05:25PM
04:25PM
04:15PM
Aug-29-23 08:46AM
Aug-28-23 11:43AM
Aug-25-23 08:02AM
Aug-24-23 12:10PM
Aug-15-23 03:41PM
Aug-13-23 08:23AM
Aug-10-23 09:05PM
Aug-09-23 06:46AM
Aug-07-23 01:18PM
Aug-02-23 04:14PM
Jul-27-23 04:33PM
Jul-26-23 04:15PM
Jul-17-23 07:05AM
04:37AM
Jul-13-23 02:00PM
10:00AM
Jul-12-23 04:15PM
11:40AM
Jul-03-23 10:30AM
Jun-28-23 10:19AM
Jun-23-23 11:40AM
Jun-21-23 08:00PM
Jun-15-23 07:52PM
Jun-09-23 07:13PM
Jun-07-23 11:40AM
Jun-06-23 03:39PM
Jun-05-23 09:35AM
07:21AM
Jun-02-23 05:45PM
02:07PM
(Thomson Reuters StreetEvents)
11:35AM
10:05AM
Jun-01-23 06:00PM
05:35PM
04:26PM
04:15PM
May-30-23 08:03AM
May-25-23 12:00PM
09:40AM
May-23-23 04:15PM
May-22-23 11:40AM
May-18-23 05:15AM
May-16-23 09:45AM
May-12-23 06:04AM
May-11-23 05:35PM
May-09-23 05:05PM
07:45AM
May-04-23 11:40AM
08:15AM
Apr-27-23 04:15PM
05:13AM
Apr-26-23 08:00PM
10:33AM
Apr-25-23 08:45AM
Apr-18-23 01:55PM
Apr-13-23 06:26AM
Apr-06-23 10:35AM
Apr-04-23 08:23PM
Mar-30-23 11:40AM
Mar-29-23 01:49PM
The Cooper Cos, Inc. operates as a medical device company. It operates through the Cooper Vision and Cooper Surgical segments. The Cooper Vision segment develops, manufactures, and markets products for contact lens wearers, which solves vision challenges such as astigmatism, presbyopia, myopia, ocular dryness, and eye fatigues. The Cooper Surgical segment focuses on the provision of advancement for the health of women, babies, and families through women's health and fertility products and services. The company was founded in 1958 and is headquartered in San Ramon, CA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Sheffield Holly R President, CSI Jun 04 Option Exercise 356.47 1,104 393,543 4,952 Jun 07 02:45 PM WEISS ROBERT S Director Apr 01 Option Exercise 0.00 693 0 70,693 Apr 03 06:31 PM PETERSMEYER GARY S Director Apr 01 Option Exercise 0.00 630 0 2,764 Apr 03 06:30 PM Jay Colleen Director Apr 01 Option Exercise 0.00 630 0 5,977 Apr 03 06:28 PM KOZY WILLIAM A Director Apr 01 Option Exercise 0.00 662 0 6,314 Apr 03 06:29 PM Rivas Maria Director Apr 01 Option Exercise 0.00 630 0 1,132 Apr 03 06:28 PM MADDEN TERESA S Director Apr 01 Option Exercise 0.00 630 0 1,686 Apr 03 06:27 PM Lucchese Cynthia L Director Apr 01 Option Exercise 0.00 512 0 512 Apr 03 06:25 PM Ricupati Agostino SVP & CAO Mar 31 Sale 370.00 1,000 370,000 863 Apr 03 06:32 PM PETERSMEYER GARY S Director Mar 15 Sale 335.78 700 235,044 2,134 Mar 15 04:18 PM Warner Gerard H III President, CooperVision, Inc. Mar 09 Sale 340.53 1,216 414,087 1,290 Mar 09 06:03 PM WEISS ROBERT S Director Mar 07 Option Exercise 131.60 37,510 4,936,316 107,510 Mar 07 07:42 PM WEISS ROBERT S Director Mar 07 Sale 337.72 37,510 12,667,880 70,000 Mar 07 07:42 PM Warner Gerard H III President, CooperVision, Inc. Jan 08 Option Exercise 0.00 2,467 0 3,790 Jan 10 04:42 PM Sheffield Holly R President, CSI Jan 08 Option Exercise 0.00 589 0 4,143 Jan 10 04:41 PM Ricupati Agostino SVP & CAO Jan 08 Option Exercise 0.00 459 0 2,179 Jan 10 04:40 PM Andrews Brian G EVP, CFO & Treasurer Jan 08 Option Exercise 0.00 108 0 2,270 Jan 10 04:39 PM Lindell Jody S Director Jan 06 Option Exercise 128.35 1,000 128,350 14,543 Jan 10 04:36 PM Lindell Jody S Director Jan 06 Sale 344.30 1,000 344,304 13,543 Jan 10 04:36 PM PETERSMEYER GARY S Director Dec 12 Option Exercise 156.51 1,282 200,649 3,034 Dec 14 05:30 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite